C-reactive protein, body mass index, and diabetic retinopathy.
about
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyRelationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-AnalysisEpidemiology of diabetic retinopathy, diabetic macular edema and related vision lossNew Therapeutic Approaches in Diabetic Retinopathy.The significance of screening for microvascular diseases in Chinese community-based subjects with various metabolic abnormalitiesThe Role of Systemic Risk Factors in Diabetic RetinopathyBody mass index and risk of diabetic retinopathy: A meta-analysis and systematic review.Risk factors for proliferative diabetic retinopathy in a Latino American population.The role of microglia in diabetic retinopathyDiabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy.Retinopathy among young adults with Diabetes Mellitus from a tertiary care setting in Sri Lanka.C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetesCirculating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.The metabolic syndrome and severity of diabetic retinopathy.P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans.Epidemiological characteristics and risk factors of diabetic retinopathy in type 2 diabetes mellitus in Shandong Peninsula of China.Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammalsC-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitusRetinopathy in youth with type 2 diabetes participating in the TODAY clinical trial.TCF7L2 variation and proliferative diabetic retinopathyBody mass index: a risk factor for retinopathy in type 2 diabetic patients.Body mass index and retinopathy in type 1 diabetic patients.Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies.Current epidemiology of diabetic retinopathy and diabetic macular edema.Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.Neural inflammation and the microglial response in diabetic retinopathy.Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis.Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations.The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis.C-reactive protein may be useful to differentiate idiopathic orbital inflammation and orbital cellulitis in cases with acute eyelid erythema and edema.
P2860
Q26744760-04E0BFFD-9DA3-42C7-B03D-00E1493F64E4Q26774344-B02DF008-CC4C-4496-AACC-75FC6E0F6A98Q26775552-392B53AD-9534-485D-ABF6-2B512B04366BQ33583037-15FAC922-06E9-42CA-9BCA-B0BDF6CBEEB2Q33623669-16E1737C-488F-43B6-8070-1EFB79C1EC50Q33689773-AE15B387-F681-463C-B2FD-27C86BCF7B44Q33765398-F88C0F58-1256-4946-8C0F-FF10063BA37AQ33946519-622842D0-C452-496E-802E-B12605594F2AQ34199146-3497C6AD-CB47-4FEA-962B-E06EB086FD0AQ34263212-397E1E42-7777-4AC7-9329-AF7992724585Q35109447-BEB77C9F-9E8D-4E66-8B69-99560BEE92D8Q35151396-8EC56AA9-6ABD-4823-A186-836FE807334EQ35434512-21B1832B-CC4F-4F87-A734-AB622A9EB8FCQ35586571-532480A7-7666-40A3-838D-BF4CA564FE5FQ35589517-7469BDCF-A823-4197-9CBC-46B9405ABADBQ35923901-77036FB4-2A80-4AE0-A64D-653616DD1D7DQ36051041-3F088BCE-AB15-47AC-A96C-83CE6761E2E7Q36622467-D464C62C-06B1-472D-AA8D-B3BB0F04A71BQ36868268-699B92B9-D610-4AEB-9908-BC07F1D75D5EQ37015022-1008E98A-2E1E-49FD-8041-8547DA5F5F29Q37368103-9DE5B0B8-D0C2-4FEE-93AF-F9ACDE81409BQ37628516-F6B207D8-B2C7-4F8B-9522-3594561AB211Q37972865-06C4EAB5-74F9-4685-AD0A-99C8269024EEQ38010064-08E6C545-EDA6-461D-A309-DA3AC707A7F4Q38682902-8D086593-2483-44DF-B23C-E3D5695E4886Q40064446-CDF6777B-5000-45D4-AC66-AAB7719EEEA2Q42144753-2F75CD2E-6D21-44F7-9155-FCAE1C10BB1FQ43885680-59865141-45FD-4FD6-8CE2-0BBA93C8A907Q46068772-5F8B9C51-1BE8-4E12-A505-2347BC2CD3F2Q55325329-8ECA5D79-FD6B-4A13-8CC1-DFDCAC25B925Q55512530-E3DF3293-1198-4651-9B94-113A511F6070Q55517057-1833DD62-03BA-4767-A33A-432319C9D2B8
P2860
C-reactive protein, body mass index, and diabetic retinopathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
C-reactive protein, body mass index, and diabetic retinopathy.
@en
C-reactive protein, body mass index, and diabetic retinopathy.
@nl
type
label
C-reactive protein, body mass index, and diabetic retinopathy.
@en
C-reactive protein, body mass index, and diabetic retinopathy.
@nl
prefLabel
C-reactive protein, body mass index, and diabetic retinopathy.
@en
C-reactive protein, body mass index, and diabetic retinopathy.
@nl
P2093
P50
P356
P1476
C-reactive protein, body mass index, and diabetic retinopathy.
@en
P2093
Jie Jin Wang
Laurence Shen Lim
Tien Yin Wong
Wan Ting Tay
P304
P356
10.1167/IOVS.09-4939
P407
P577
2010-09-01T00:00:00Z